Adherence to Anti-Osteoporotic Treatment and Clinical Implications after Hip Fracture: A Systematic Review

Effect of Zoledronate on Lower Respiratory Infections in Older Women: Secondary Analysis of a Randomized Controlled Trial

(2021) Ian R. Reid et al.   CALCIFIED TISSUE INTERNATIONAL

Experience gained from the implementation of the fracture liaison service in Greece

(2020) Polyzois Makras et al.   Archives of Osteoporosis

A national study on long-term osteoporosis therapy and risk of recurrent fractures in patients with hip fracture

(2020) Chiao-Lin Hsu et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Alendronate medication possession ratio and the risk of second hip fracture: an 11-year population-based cohort study in Taiwan

(2020) Y.J. Chen et al.   OSTEOPOROSIS INTERNATIONAL

Nitrogen‐Containing Bisphosphonates Are Associated With Reduced Risk of Pneumonia in Patients With Hip Fracture

(2020) Chor‐Wing Sing et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Efficacy of Teriparatide in Improving Fracture Healing in Hip Fractures: A Systematic Review and Meta-Analysis

(2020) Shuang Han et al.   Biomed Research International

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures

(2019) Zhong Liu et al.   Orthopaedic Surgery

Bisphosphonates and mortality: confounding in observational studies?

(2019) J. Bergman et al.   OSTEOPOROSIS INTERNATIONAL

Treatment Effects of Bisphosphonates and Denosumab on Survival and Refracture from Real-World Data of Hip-Fractured Patients

(2019) Martina Behanova et al.   CALCIFIED TISSUE INTERNATIONAL

Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study

(2019) D. González-Quevedo et al.   OSTEOPOROSIS INTERNATIONAL

Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates

(2019) Steven R. Cummings et al.   JAMA Internal Medicine

Anti‐Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture

(2019) Pei‐wen Wang et al.   Orthopaedic Surgery

Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture

(2019) Adem Cobden et al.   Archives of Osteoporosis

VIRTUAL ORTHOPEDIC-REHABILITATION-METABOLIC COLLABORATION FOR TREATING OSTEOPOROTIC HIP FRACTURES

(2019) Osnat Tell Lebanon et al.   Endocrine Practice

The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study

(2019) Shahab Abtahi et al.   Journal of the American Medical Directors Association

Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture

(2018) Chor-Wing Sing et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Characteristics of recurrent fractures

(2018) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

The relation of low levels of bone mineral density with coronary artery calcium and mortality

(2018) N. Ahmadi et al.   OSTEOPOROSIS INTERNATIONAL

Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study

(2018) Tineke A. C. M. van Geel et al.   PLoS One

ORTHOPEDIC-METABOLIC COLLABORATIVE MANAGEMENT FOR OSTEOPOROTIC HIP FRACTURE

(2018) Pnina Rotman-Pikielny et al.   Endocrine Practice

Bisphosphonate Use After Hip Fracture in Older Adults: A Nationwide Retrospective Cohort Study

(2017) Peter Nordström et al.   Journal of the American Medical Directors Association

Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis

(2017) T. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

(2017) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Evaluation of the geriatric co-management for patients with fragility fractures of the proximal femur (Geriatric Fracture Centre (GFC) concept): protocol for a prospective multicentre cohort study

(2017) Alexander Joeris et al.   BMJ Open

Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium

(2017) A. Fahrleitner-Pammer et al.   Archives of Osteoporosis

Geographic variation in secondary fracture prevention after a hip fracture during 1999–2013: a UK study

(2016) A. Shah et al.   OSTEOPOROSIS INTERNATIONAL

Imminent risk of fracture after fracture

(2016) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis

(2015) S. Palacios et al.   CLIMACTERIC

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

(2015) P. Hadji et al.   OSTEOPOROSIS INTERNATIONAL

Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study

(2015) W. Brozek et al.   OSTEOPOROSIS INTERNATIONAL

The Osteoporosis Treatment Gap

(2014) John A Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Risk Analysis for Second Hip Fracture in Patients After Hip Fracture Surgery: A Nationwide Population-Based Study

(2014) Shih-Hsun Shen et al.   Journal of the American Medical Directors Association

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

(2013) K. Åkesson et al.   OSTEOPOROSIS INTERNATIONAL

Bisphosphonate use and subsequent hip fracture in South Korea

(2013) Y.-K. Lee et al.   OSTEOPOROSIS INTERNATIONAL

Trends in the incidence of hip fractures

(2013) K. Senohradski et al.   OSTEOPOROSIS INTERNATIONAL

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

(2013) D. Prieto-Alhambra et al.   OSTEOPOROSIS INTERNATIONAL

The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction

(2012) Carsten Goessl et al.   Annals of the New York Academy of Sciences

Characteristics and outcome in patients sustaining a second contralateral fracture of the hip

(2012) S. Sawalha et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study

(2012) L. Bondo et al.   OSTEOPOROSIS INTERNATIONAL

Bone mineral density and all-cause, cardiovascular and stroke mortality: A meta-analysis of prospective cohort studies

(2011) Xinhua Qu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

(2011) Matthew Austin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men

(2011) Jacqueline R. Center et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture

(2011) Steven Boonen et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women

(2011) M. Osaki et al.   OSTEOPOROSIS INTERNATIONAL

Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment

(2011) L. Boudou et al.   OSTEOPOROSIS INTERNATIONAL

Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision

(2011) A. R. McLellan et al.   OSTEOPOROSIS INTERNATIONAL

Missed Opportunities for Osteoporosis Treatment in Patients Hospitalized for Hip Fracture

(2010) Lee A. Jennings et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study

(2010) P. N. Sambrook et al.   OSTEOPOROSIS INTERNATIONAL

Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women

(2009) T. Suzuki et al.   OSTEOPOROSIS INTERNATIONAL

In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients

(2008) Daniele Santini et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Mortality following hip fracture: Trends and geographical variations over the last 40 years

(2008) S. Haleem et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED